NeueHealth Overview
NeueHealth (NEUE) has a ROE of 8.88%, below the Finance sector average of 16.22%.
Get informed when a big investor buys or sells
+ Follow8.88%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for NEUE is 8.88%. That is below the Finance sector average of 16.22%. Investors often review this figure alongside NeueHealth's historical trend and sector peers before judging valuation or financial health.
Against Finance companies, NEUE currently prints 8.88% for ROE, while the sector average sits near 16.22%. That is roughly 45.3% below the sector mean. Large gaps often invite a closer look at NeueHealth's growth, margins, and balance sheet.
Return on Equity shows how effectively NeueHealth converts resources into returns. At 8.88%, NEUE may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting NEUE's ROE (8.88%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack NeueHealth's ROE against similar Finance names. You can also browse sector and industry screens on Stockcircle for a broader set of Finance companies and their key multiples and fundamentals.
